The European Commission does not appreciate the delays in the delivery of vaccines against Covid-19. After having been relatively indulgent with Pfizer-BioNTech, with whom a compromise seems to have been found (see EUROPE B12640A1), the institution hardened its tone with AstraZeneca on Monday 25 January, which has also just announced problems with the delivery of its candidate vaccine.
The institution also proposed to Member States at a meeting of the Steering Board on Vaccine Advance...